SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.84+1.8%Dec 19 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (14853)12/22/2004 1:39:15 AM
From: BulbaMan  Read Replies (1) of 52153
 
I don't doubt virtually all docs currently believe the risk/benefit picture for statins looks great. But it's expected that many millions of people will be taking statins for decades and my fear is major problems with the drugs will show up before long. For example, there's already evidence that statins deplete Coenzyme Q10, but very few docs recommend CoQ10 supplementation to their patients on statins. Statins are being mass-marketed to consumers (and docs) by the big drug companies (just like the Cox-2 inhibitors), and it's a certainty many are being convinced to take the drugs when the benefits are marginal and don't outweigh the potential risks. Advertising generally does work.
P.S. I totally agree with Zeta that for many pain sufferers relief is not optional.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News